| The international decision support initiative reference case for economic evaluation: an aid to thought T Wilkinson, MJ Sculpher, K Claxton, P Revill, A Briggs, JA Cairns, ... Value in health 19 (8), 921-928, 2016 | 252 | 2016 |
| Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program JB Carlin, KK Macartney, KJ Lee, HE Quinn, J Buttery, R Lopert, J Bines, ... Clinical Infectious Diseases 57 (10), 1427-1434, 2013 | 230 | 2013 |
| Comparative effectiveness research and evidence‐based health policy: experience from four countries K Chalkidou, S Tunis, R Lopert, L Rochaix, PT Sawicki, M Nasser, B Xerri The Milbank Quarterly 87 (2), 339-367, 2009 | 199 | 2009 |
| A randomized controlled trial of piroxicam in the management of acute ankle sprain in Australian Regular Army recruits: the Kapooka Ankle Sprain Study MA Slatyer, MJ Hensley, R Lopert The American journal of sports medicine 25 (4), 544-553, 1997 | 136 | 1997 |
| The high price of “free” trade: US trade agreements and access to medicines R Lopert, D Gleeson Journal of Law, Medicine & Ethics 41 (1), 199-223, 2013 | 116 | 2013 |
| Disinvestment and value-based purchasing strategies for pharmaceuticals: an international review B Parkinson, C Sermet, F Clement, S Crausaz, B Godman, S Garner, ... Pharmacoeconomics 33, 905-924, 2015 | 106 | 2015 |
| Drug-induced delirium: incidence, management and prevention GL Carter, AH Dawson, R Lopert Drug safety 15, 291-301, 1996 | 72 | 1996 |
| Toward a definition of pharmaceutical innovation S Morgan, R Lopert, D Greyson Open medicine 2 (1), e4, 2008 | 70 | 2008 |
| Biosimilars and the European experience: implications for the United States F Megerlin, R Lopert, K Taymor, JH Trouvin Health Affairs 32 (10), 1803-1810, 2013 | 56 | 2013 |
| How the Trans Pacific Partnership Agreement could undermine PHARMAC and threaten access to affordable medicines and health equity in New Zealand D Gleeson, R Lopert, P Reid Health Policy 112 (3), 227-233, 2013 | 52 | 2013 |
| Does medication adherence lower Medicare spending among beneficiaries with diabetes? B Stuart, A Davidoff, R Lopert, T Shaffer, J Samantha Shoemaker, J Lloyd Health services research 46 (4), 1180-1199, 2011 | 50 | 2011 |
| Differential pricing of drugs: a role for cost-effectiveness analysis? R Lopert, DL Lang, SR Hill, DA Henry The Lancet 359 (9323), 2105-2107, 2002 | 50 | 2002 |
| Evidence-based decision-making within Australia's pharmaceutical benefits scheme R Lopert Commonwealth Fund, 2009 | 46 | 2009 |
| Prices for innovative pharmaceutical products that provide health gain: a comparison between Australia and the United States EE Roughead, R Lopert, LN Sansom Value in Health 10 (6), 514-520, 2007 | 46 | 2007 |
| Use of pharmacoeconomics in prescribing research. Part 3: cost‐effectiveness analysis–a technique for decision‐making at the margin R Lopert, DL Lang, SR Hill Journal of clinical pharmacy and therapeutics 28 (3), 243-249, 2003 | 44 | 2003 |
| Use of pharmacoeconomics in prescribing research. Part 5: modelling–beyond clinical trials DL Lang, R Lopert, SR Hill Journal of clinical pharmacy and therapeutics 28 (5), 433-439, 2003 | 39 | 2003 |
| The trans Pacific partnership agreement, intellectual property and medicines: differential outcomes for developed and developing countries D Gleeson, J Lexchin, R Lopert, B Kilic Global Social Policy 18 (1), 7-27, 2018 | 36 | 2018 |
| Applying rapid ‘de-facto’HTA in resource-limited settings: experience from Romania R Lopert, F Ruiz, K Chalkidou Health Policy 112 (3), 202-208, 2013 | 34 | 2013 |
| Implementing health technology assessment in Ghana to support universal health coverage: building relationships that focus on people, policy, and process S Hollingworth, M Gyansa-Lutterodt, L Dsane-Selby, J Nonvignon, ... International journal of technology assessment in health care 36 (1), 8-11, 2020 | 31 | 2020 |
| Impact of Medication Adherence on Medicare Expenditure among Beneficiaries with Heart Failure. R Lopert, JS Shoemaker, B Stuart, A Davidoff American Journal of Managed Care 18 (9), 556-63, 2012 | 31 | 2012 |
Deborah GleesonLa Trobe University在 latrobe.edu.au 的电子邮件经过验证
